Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q2 2024 Earnings Call Transcript

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q2 2024 Earnings Call Transcript July 31, 2024

Fulcrum Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.871, expectations were $-0.06.

Operator: Good morning and welcome to Fulcrum’s Therapeutics Second Quarter 2024 Financial Results and Business Update Conference Call. [Operator Instructions]. This call is being webcast live, and can be accessed on the Investors section of Fulcrum’s website at www.fulcrumtx.com, and is being...